Pay in 4 interest-free payments of $7.47 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Emory University School of Law
Kraft M, Kraft K, Grtner S, Mayerle J, Simon P, Weber E, Schtte K, Stieler J, Koula-Jenik H, Holzhauer P, Grber U, Engel G, Mller C, Feng YS, Aghdassi A, Nitsche C, Malfertheiner P, Patrzyk M, Kohlmann T, Lerch MM
J Dermatol Treat (2022) 33(3):142834
doi: 10.1016/j.biopha.2021.111315 2 RawshaniARawshaniAFranznSSattarNEliassonBSvenssonAMet al
Being the first dual GLP-1/GIP receptor agonist to be approved in clinical practice, tirzepatide has better efficacy than the conventional GLP-1 monotherapy
US$ 26.33
US$ 28.98
US$ 24.53
US$ 21.71
US$ 29.67
US$ 28.61
US$ 21.72
